Certain A Shares of Henan Newland Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-NOV-2023. These A Shares will be under lockup for 373 days starting from 9-NOV-2022 to 17-NOV-2023.

Details:
The company?s holding shareholder Henan Shuangji Industrial Co., Ltd., actual controller Xie Jianzhong promised within 36 months after the listing date, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period will automatically be extended for at least 6 months.

Shareholder Changge Zhongyuan Trading Co., Ltd. promised within 36 months after the listing date, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period will automatically be extended for at least 6 months.

Newly added shareholder within 12 months prior to IPO application Li Jindeng promised within 36 months after obtaining company shares or within 12 months after the listing date (whichever is later), will not transfer nor entrust to others for management direct or indirect shares in the company held prior to issuance, nor allow the company to repurchase the said shares.

Directors, supervisors, management personnel promised within 12 months after the listing date, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. During the term of office in the company, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period will automatically be extended for at least 6 months.